United Therapeutics Corporation (UTHR)
NASDAQ · Healthcare
United Therapeutics Corporation Gross Profit 2008–2025
United Therapeutics Corporation annual/quarterly gross profit history and growth rate from 2009 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- United Therapeutics Corporation gross profit for the quarter ending March 31, 2026 was 648.1 M, a 7.66% decrease year-over-year.
- United Therapeutics Corporation gross profit for the twelve months ending March 31, 2026 was 2.8 B, a 12.77% increase year-over-year.
- United Therapeutics Corporation annual gross profit for 2025 was 2.8 B, a 8.98% increase from 2024.
- United Therapeutics Corporation annual gross profit for 2024 was 2.6 B, a 24.04% increase from 2023.
- United Therapeutics Corporation annual gross profit for 2023 was 2.1 B, a 15.99% increase from 2022.
- United Therapeutics Corporation annual gross profit for 2022 was 1.8 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
United Therapeutics Corporation Gross Profit — FAQ
United Therapeutics Corporation (UTHR) gross profit over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is United Therapeutics Corporation's gross profit?
United Therapeutics Corporation (UTHR) reported gross profit of $2.80B for fiscal 2025.
Where can I see UTHR's gross profit history?
The chart and table above show United Therapeutics Corporation's gross profit by year and by quarter, including the growth rate.